A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.
Clinical trial NCT05286567 · COMPLETED
Trial details
- NCT number
- NCT05286567
- Sponsor
- Aarhus University Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-08-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.